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1. Introduction
  High cholesterol diet is regarded as a crucial factor in 
the development of hypercholesterolemia, atherosclerosis 
and ischemic heart disease. Cardiovascular disease is the 
primary cause of mortality in the United States, Europe 
and most parts of Asia[1]. In hypercholesterolemia, the 
cholesterol content was elevated in serum as well as in 
erythrocytes, platelets and endothelial cells. This increased 
cholesterol is reported to activate these cells and cause 
the enhanced production of oxygen free radicals[2,3]. The 
elevation of serum total cholesterol and low-density 
lipoprotein (LDL) cholesterol as well as alteration of other 
lipid parameters has been implicated as a primary risk 
factor for cardiovascular disease[4-6].
  Raised serum lipid levels, particularly of cholesterol along 
with generation of reactive oxygen species (ROS) play a 
key role in the development of coronary artery disease 
and atherosclerosis[7]. The body has evolved a complex 
defense strategy to minimize the damaging effects of 
various oxidants, central to this defense are the antioxidant 
enzymes. They include superoxide dismutase (SOD), 
glutathione peroxidase (GPx), and catalase (CAT) which act 
in concert to protect the organism from oxidative damage[8].
  Varieties of plants have been used traditionally in the 
treatment of various cardiovascular diseases. A number of 
plants with potent therapeutic components such as fibers, 
phytosterols, saponins, polyphenols, flavanoids, etc., have 
been investigated for their antihyperlipidemic, antioxidant 
and anti atherosclerotic properties[9].
  Bacopa monniera (Linn) wettst. (Syn. Herpestis monniera 
(Linn.H.B) (B. monniera) is a small creeping herb known 
as Brahmi in Ayurvedic medicine and is widely used in 
India, especially for enhancing memory, analgesia (pain 
relief), and epilepsy[10]. B. monniera has traditionally 
been used to treat asthma, hoarseness, mental disorders, 
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improve mental performance, nervine tonic, cardiotonic and 
diuretic (increases urine flow)[11]. Preclinical and clinical 
studies have shown that B. monniera improves memory and 
mental function[12]. The plant has been shown to possess a 
potent free radical scavenging and antioxidant properties[13]. 
Besides it also exhibits cardio-protective[14], vasodilatory [15], 
anti-inflammatory[16], calcium antagonistic[17], mast cell 
stabilizing[18], antiulcer[19] and anti-addictive[20] properties.
  B. monniera has been reported to contain triterpenoid 
saponins, alkaloids and flavonoids[21,22]. Despite the 
availability of literature on the medicinal properties of B. 
monniera and its chemical constituents, no report exits 
on its hypocholesterolmic properties. We therefore have 
attempted to investigate the effect of B. monniera on diet 
induced hypercholesterolemia in rats by monitoring lipid 
and lipoprotein status, antioxidant status, cardiac marker 
enzyme and histological changes of aorta.
2. Materials and methods
2.1. Collection of plant material and extraction procedure
  The plant material was collected at Chennai, Tamil Nadu 
and was authenticated by Dr.P.Brindha, Botanist, Captain 
Srinivasa Murthi Drug Research Institute for Ayurveda, 
Arumbakkam, Chennai, India. The shade-dried and coarsely 
powdered whole plant material (1kg) was extracted with 
90% ethanol in the cold (48 h). The extract was filtered and 
distilled on a water bath to get a dark green syrupy mass. 
It was finally dried in vacuo (52 g). The alcoholic extract of
B. monniera (AEBM) was dissolved in water and given orally 
as a suspension.
2.2. Experimental animals
  Healthy male albino rats of Wistar strain weighing (200依
250) g were used for the present study. The animals were 
purchased from Central Animal House Block, Dr. ALM PG 
IBMS, University Of Madras, Taramani Campus, Chennai-
113. The animals were housed in large spacious cages. 
Food and water were given ad libitum. The animal house 
was ventilated with a 12 h light/dark cycle, throughout 
the experimental period. Rats were allowed to adapt to 
their environment condition for at least 10 days before 
the initiation of experiment. All experiment and protocols 
described in this study were approved by the Institutional 
Animal Ethics Committee (IAEC No: 01/09/10) of Dr.ALM 
PGIBMS, University of Madras, Taramani Campus, Chennai-
113. 
  The rats were randomly divided into four groups of six rats 
each.
Group  I  Control rats fed with normal diet.
Group II  Rats fed with hypercholesterolemic diet (HCD) for 
45 days [rat chow supplemented with 4% cholesterol (w/w) 
and 1% cholic acid (w/w)].
Group III Rats fed with HCD for 45 days[23] + administrated 
with AEBM (40mg/kg, body weight/day orally) for last 30 
days.
Group IV Rats fed with normal diet for 45 days + administrated 
with AEBM (40 mg/kg, body weight/day orally)[20] for last 30 
days.
  At the end of the experimental period (45 days), the 
animals were fasted overnight and sacrificed by cervical 
decapitation. The aorta and liver tissues were excised 
immediately, washed with ice-cold saline and then 
dried with filter paper. A 10% homogenate of liver were 
prepared by using 0.1M Tris HCl buffer pH 7.4. The slice 
of aorta tissue was fixed with 10% formalin amd stained 
with Haematoxylin and eosin stain for histopathological 
studies. Blood was collected in two different tubes, i.e., one 
with anticoagulant-EDTA for the separation of plasma and 
another without anticoagulant for the serum. The above 
samples were used for biochemical analysis.
2.3. Chemicals
  Lipid profile kit purchased from Spin React (Spain). Nitro 
Blue Tetrazolium (NBT), L-毩-phosphatidyl choline was 
obtained from Sigma chemicals (St. Louis, USA). Hydrogen 
peroxide (H2O2), Chromatrophic acid, 5,5’ Dithiobis-(2-
nitrobenzoic acid) (DTNB), Sodium dodecyl sulphate (SDS), 
Ethylene-diaminetetra acetic acid (EDTA), dextran sulphate, 
Trichloro acetic acid (TCA) and Formalin were obtained 
from SRL, Mumbai, India.  Folin Ciocalteau reagent, 
Thiobarbituric acid (TBA) Sialic acid was obtained from 
CDH, New Delhi, India. 
2.4. Biochemical analysis
  Plasma total cholesterol (TC), triglyceride (TG), 
phospholipids (PL), LDL-C, VLDL-C and HDL-C levels were 
measured using commercial kits from Spin react (Girona, 
Spain) according to the manufacturer’s specifications. 
LDL/HDL ratio, TC/HDL ratio, and atherogenic index (AI) 
were calculated by the method[24]. Activity staining of SOD 
8% and CAT 5% on gel were performed by using a native 
gel activity stain[25]. The antioxidant enzyme viz., GPx [26], 
GR[27] and GST[28] were estimated according to the reported 
methods. The GSH content in liver were measured by the 
method[29]. The lipid peroxidation product (LPO) in liver was 
measured by the method [30]. Serum cardiac marker enzymes 
Viz., SGOT[31], LDH[32] and CPK[33] were also evaluated 
according to the reported method. Protein was estimated by 
the method [34].
2.5. Histopathological studies
  A midline thoracotomy was performed and the portion of 
thoracic aorta was quickly removed with heart from control 
and experimental animal and were fixed in 10% formalin, 
then dehydrated in the descending grades of isoproponol 
and xylene. The aorta was then embedded in molten paraffin 
wax and sectioned at 5 毺m thickness and were stained 
with hematoxylin and eosin (H&E), viewed under light 
microscope for histological changes.
2.6. Statistical analysis 
  The values were expressed as mean 依 SD (n=6) for six 
animals in each group. Differences between each group were 
assessed by one way analysis of variance (ANOVA) using 
SPSS 17 version and least significant difference (LSD) was 
determined using Post hoc test at  the level of P<0.05.
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3. Results 
3.1. Effect of AEBM on plasma lipid status
  The levels of plasma total cholesterol (TC), triglyceride 
(TG) and Phospholipids (PL) were given in Figure 1. The 
levels of plasma TC, TG, PL were significantly (P<0.01) 
increased in HCD induced rats when compared to normal 
rats. Treatment with AEBM significantly reverted the HCD 
induced alterations in the levels of plasma TC, TG (P<0.01) 
and PL (P<0.05) when compared to HCD group.
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Figure 1. Effect of AEBM on plasma lipid status (TC, TG, PL) in 
control and experimental rats.
Values were expressed as mean ± S.D for 6 rats in each group.
*P<0.05 compared with control, **P<0.01 compared with control.
 #P<0.05 compared with HCD, ##P<0.01 compared with HCD
3.2. Effect of AEBM on the level of plasma lipoproteins and 
ratios
  Table 1 shows the effect of AEBM on the levels of plasma 
lipoproteins (HDL, LDL, VLDL) and the ratio of LDL/HDL, 
TC/HDL and atherogenic index of control and experimental 
rats. A significant (P<0.01) increase in the levels of LDL, 
VLDL, LDL/HDL ratio, TC/HDL ratio and atherogenic index 
with a significant decrease (P<0.01) in the level of HDL were 
observed in HCD induced rats when compared to control 
rats. Treatment with AEBM, reverted back all the changes 
in terms of lipoprotein and its ratios to normal level when 
compared to HCD induced rats.
3.3. Effect of AEBM on activity staining of hepatic SOD and 
CAT
  Figure 2 and 3 shows the activity staining of hepatic 
superoxide dismutase (SOD) and catalase (CAT) in control 
and experimental rats by Native-PAGE. A marked decrease 
in the activity staining of the SOD and CAT, were observed 
in HCD induced rats (lane 2) when compared to control 
rats. AEBM treatment (lane 3) restores the HCD induced 
alterations in the activity staining of the SOD and CAT to 
near control. AEBM alone treated rats (lane 4) did not show 
any changes in the activity staining of the SOD and CAT and 
resembled very much similar to that of control rats (lane 1).
1                                   2                                    3                                 4
Figure 2. Activity staining of hepatic SOD in control and experimental 
rats by Native-PAGE.  
1                                   2                                    3                                 4
Figure 3. Activity staining of hepatic CAT in control and experimental 
rats by Native-PAGE. 
Table 1 
Effect of AEBM on the level of plasma lipoproteins and ratios in control and experimental rats.
Group
Plasma lipoproteins  (mg/dL) Ratios
HDL LDL VLDL Atherogenic index LDL/HDL TC/HDL
Control 32.60依2.14 41.37依3.17 18.45依1.27 1.83依0.14 1.26依0.11 2.83依0.25
HCD 27.92依1.05 ** 105.74依4.11 ** 21.46依1.50 ** 4.55依0.38 ** 3.78依0.33 ** 5.55依0.52 **
HCD+AEBM 30.05依1.82 ## 54.05依2.19 ## 19.70依.92.00 # 2.45依0.19 ## 1.79依0.17 ## 3.45依0.37 ##
AEBM 33.16依3.35 44.35依1.88 17.09依0.82 1.79依0.14 1.33依0.12 2.85依0.31
Values were expressed as mean 依 S.D. for 6 rats in each group, *P<0.05 compared with control, **P<0.01 compared with control,  #P<0.05 
compared with HCD, ##P<0.01 compared with HCD.
Table 2
Effect of AEBM on the activities of liver antioxidant enzymes (GPx, GR, GST) in control and experimental rats.
Group GPx (U/mg protein1) GR (U/mg protein2) GST (U/mg protein3)
Control 13.49依1.30  0.80依0.05 0.53依0.04
HCD 10.75依1.10 **  0.52依0.06 ** 0.38依0.02 **
HCD+AEBM 12.12依1.16  ##  0.68依0.10  ## 0.45依0.03  ##
AEBM 13.28依1.34  0.74依0.04 0.46依0.07 
Values were expressed as mean 依 S.D for 6 rats in each group, **P<0.01 compared with control, ##P<0.01 compared with HCD, 1毺g of GSH 
oxidized/min, 2 毺mol NADPH oxidized/min, 3 nmol CDNB-GSH conjugate/min.
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3.4. Effect of AEBM on the activities of hepatic antioxidant 
enzymes
  Activities of liver antioxidant enzymes GPx, GR and GST 
were shown in Table 2. The activities of these antioxidant 
enzymes were found to be significantly (P<0.01) reduced 
in HCD induced rats when compared to normal rats. In the 
case of AEBM treated rats, there was a pronounced increase 
(P<0.01) in the activities of these enzymes.
3.5. Effect of AEBM on the levels of hepatic LPO and GSH 
content
  Figure 4 and 5 portraits the levels of hepatic LPO and 
GSH content in control and experimental rats. Significant 
increase (P<0.01) in the level of LPO with the concomitant 
decrease (P<0.01) in glutathione content were observed in 
HCD induced groups when compared to the control rats. 
Supplementation with AEBM caused significant (P<0.05) 
restoration in the levels of glutathione content and LPO 
products, when compared to HCD induced rats.
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Figure 4. Effect of AEBM on the levels of hepatic LPO in control and 
experimental rats.
Values were expressed as mean ± S.D. for 6 rats in each group.
**P<0.01 compared with control, ##P<0.01 compared with HCD
10
9
8
7
6
5
4
3
2
1
G
SH
 ( 毺
g/
m
g 
pr
ot
ei
n)
Control
HCD
HCD+AEBM
AEBM
#
##
Figure. 5. Effect of AEBM on the levels of hepatic GSH in control and 
experimental rats.
Values were expressed as mean ± S.D. for 6 rats in each group.
**P<0.01 compared with control, ##P<0.01 compared with HCD
3.6. Effect of AEBM on the activity of serum cardiac markers 
enzymes
  The activity of serum cardiac marker enzymes where shown 
in Figure 6. In HCD induced group there is a significant 
increase (P<0.01) in the activity of serum cardiac marker 
enzymes SGOT, LDH and CPK when compared to control 
group. Treatment with AEBM significantly lowered (P<0.01) 
the activity of SGOT, LDH and CPK when compared to HCD 
group (Figure 6). AEBM alone treated group doesn’t show 
any significant change in lipid levels, antioxidant status and 
marker enzyme when compared with control rats.
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Figure 6. Effect of AEBM on the activity of serum cardiac markers 
enzymes (SGOT, LDH, CPK) of control and experimental rats.
Values were expressed as mean ± S.D. for 6 rats in each group.
**P<0.01 compared with control, ##P<0.01 compared with HCD
3.7. Effect of AEBM on Histological changes
  Figure 7A showed no pathological changes (normal intima) 
in rats of control group (100X). Figure 7B rats fed with an 
HCD developed typical plaques characterized by thickening 
of the intima, migration of smooth muscle cells to the 
intima (shown by arrow mark), adhesion and infiltration of 
macrophages, appearance of foam cells and loss of normal 
arrangement of elastic lamellae under the endothelium are 
seen (100X). Figure 7C pathological changes of thoracic 
aorta in HCD+AEBM groups were less visible than that in 
HCD alone group, but shown less thickening of the intima 
and foam cells count (100X). Figure 7D AEBM alone treated 
rats showed normal intimal-medial thickening without 
inflammatory cellular infiltration, and was similar with that 
in control group (100X).
A B
C D
Figure 7. Effect of histopathological changes of aorta in control and 
experimental rats.
Figure 7A showed no pathological changes (H&E) in rats of control 
group (100X). Figure7B rats fed with an HCD, showed development 
of typical plaque and appearance of foam cells and loss of normal 
arrangement of elastic lamellae under the endothelium (100X). Figure 
7C pathological changes of thoracic aorta of HCD+AEBM rats showed 
mild intimal thickening (100X). Figure 7D AEBM alone treated rats 
showed normal intimal-medial thickening and resembles control 
group (100X).
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Figure 8. Hplc-chromatogram of B. monniera extract.
Fiugre 8 shows the overlaid chromatogram of B. monniera extract 
by HPLC along with bacosides and other flavonoids (luteolin and 
apigenin).
4. Discussion
  Hypercholesterolemia and the resulting atherosclerosis 
have been implicated in the pathophysiology of coronary 
heart diseases and myocardial ischemia. Lowering 
cholesterol level may decrease the risk of CVD, and 
therefore enormous efforts have been extended to achieve 
this aim[7]. The hypocholesterolemic activity of alcoholic 
extract of B. monniera (AEBM) against hypercholesterolemia 
was monitored on the Lipid profile status, antioxidant status, 
activities of serum cardiac marker enzyme, level of LPO and 
histological changes of aorta.
  In this study the high cholesterol diet (HCD) is used 
which consists of normal rat chow supplemented with 4% 
cholesterol (w/w) and 1% cholic acid (w/w) because cholic 
acid improves dietary absorption of cholesterol and hence 
diet supplemented with both cholesterol and cholic acid has 
been used in many experimental hypercholesterolemia[23]. 
The diet-induced hypercholesterolmia animal model has 
long been used for the assessment of agents with beneficial 
effects on cholesterol[35].
  In the current study, the HCD fed rats showed increased 
levels of plasma cholesterol (TC), triglycerides (TG) and 
phospholipids (PL) levels compared to normal control rats. 
Treatment with AEBM significantly decrease the levels of 
plasma TC, TG, PL when compared to HCD induced rats. 
Saponins are also reported to precipitate cholesterol from 
micelles and interfere with enterohepatic circulation of 
bile acids making it unavailable for intestinal absorption, 
this forces liver to produce more bile from cholesterol 
(plasma) and hence the reduction in plasma cholesterol 
level. Saponins are also reported to lower triglycerides by 
inhibiting pancreatic lipoprotein lipase[36]. Similarly in our 
study also, the presence of both flavanoids and saponins in 
AEBM [21,22] could have been contributed in reducing the 
levels of lipid status (TC, TG, PL). 
  Elevated levels of plasma low density lipoprotein 
cholesterol (LDL) and very low density lipoprotein 
cholesterol (VLDL) are often accompanied by premature 
atherosclerosis and other CVD. A low level of high-density 
lipoprotein cholesterol (HDL) is also an important risk factor 
for cardiovascular disease[37]. The cardioprotective effects of 
HDL have been attributed to its role in reverse cholesterol 
transport, its effects on endothelial cells, and its antioxidant 
activity. Flavanoids can increase HDL-C and also decreases 
oxidation of LDL-cholesterol[38]. High cholesterol diet 
increases plasma LDL levels and oxidative stress which 
results in the production of increased oxidized LDL and 
thereby increases atherosclerotic plaque formation[39]. From 
the present study it is evident that HCD induced rats showed 
increased plasma LDL and VLDL levels with the concomitant 
reduction in plasma HDL level, when compared to normal 
rats. Supplementation with AEBM reduced the plasma 
LDL and VLDL levels and increased the plasma HDL level 
which could be due to reduction in plasma total cholesterol 
and increasing LDL receptor activity by the flavanoids and 
phytosterol present in the plant extract. Also it could be 
presumed that the reduction of total cholesterol by AEBM 
could have been associated with a reduction of its LDL 
fraction, which is the target of several hypolipidemic drugs. 
  LDL/HDL and TC/HDL ratio had direct correlation with the 
cardiovascular disease (CVD) risk. An increase in the LDL/
HDL and TC/HDL ratio is directly proportional to increased 
risk of CVD. From our study, we observed that, the HCD 
fed rats showed increased levels of Atherogenic index (AI), 
LDL/HDL and TC/HDL ratio compared to normal control 
rats. Supplementation with AEBM markedly decreases the 
Atherogenic index (AI), LDL/HDL and TC/HDL ratio due to 
its action on reducing the plasma total cholesterol level.
  Oxidative stress is believed to contribute to the 
pathogenesis of hypercholesterolemic atherosclerosis hence, 
various antioxidant compounds are being evaluated for 
potential anti-hypercholesterolemic effects[9]. A high fat diet 
brings about remarkable modifications in the antioxidant 
defence mechanisms of rat tissues by the process of 
lipid peroxidation. Several reports have shown that 
hypercholesterolemia diminishes the antioxidant defence 
systems[40] by producing free radicals and thereby elevating 
the lipid peroxide products, resulting in the production of 
toxic intermediates. 
  SOD is the first enzyme in antioxidant defense that 
protects tissues against oxygen free radicals by catalyzing 
the removal of superoxide radical (O2-), which damages the 
membrane and biological structures[41]. CAT has been shown 
to be responsible for the detoxification of significant amounts 
of H2O2[42]. SOD and CAT are the two major scavenging 
enzymes that remove the toxic free radicals. From our 
study we observed that there was a reduction in the activity 
staining of hepatic SOD and CAT in HCD induced rats (lane 
2) when compared to control rats (lane 1), this may be due to 
the enhanced production of Reactive Oxygen Species (ROS) 
by HCD. This free radical affects the antioxidant activity 
and hence resulted in the decreased activity staining of 
SOD and CAT. Treatment with AEBM (lane 3) restores the 
HCD induced alteration in the activity of staining of the SOD 
and CAT to near control due to its free radical scavenging 
activity.
  The glutathione-S-transferase (GST) family of enzymes 
comprises a long list of cytosolic, mitochondrial, and 
microsomal proteins that catalyze the conjugation of reduced 
glutathione via the sulfhydryl group, to electrophilic centers 
on a wide variety of substrates[43]. This activity is useful 
in the detoxification of endogenous compounds such as 
deoxidized lipids[44]. GPx has been shown to be responsible 
for the detoxification of H2O2. Glutathione reductase is 
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responsible for the reduction of oxidised glutathione to 
glutathione (reduced). The increased oxidant stress in 
hypercholesterolemic conditions exhausts the GSH pools[35].
  Activities of hepatic antioxidant enzymes viz., Glutathione 
peroxidase (GPx) and Glutathione Reductase (GR) enzymes 
and Glutathione contents were significantly decreased in 
HCD induced rats. On oral administration with AEBM, the 
activities of these antioxidant enzymes in liver were reverted 
back to normal level. Earlier it has been reported that AEBM 
has an antioxidant activity owing to the presence of its 
saponins, flavanoids and phytosterol[13].
  LPO is regarded as one of the basic mechanisms 
of cellular damage caused by free radicals[45]. The 
relationship between LPO and hypercholesterolemia is 
well recognized, a cholesterol rich diet results in increased 
LPO by the induction of free radical production[46]. 
Hypercholesterolemia and lipid peroxidation are believed to 
be critically involved in development of Atherosclerosis[47]. 
In our study we found that a significant increase in LPO 
levels were observed in HCD fed groups when compared to 
the control group. AEBM supplementation brought down the 
level of LPO to near normal. It has been already reported that 
AEBM has an antioxidant activity owing to the presence of 
its saponins, flavanoids and phytosterol[13], thus it decrease 
the concentration of free radicals, which might terminate the 
initiation and propagation of LPO. 
  Several reports showed that high cholesterol level can 
cause cardiac damage[48-50]. Elevation in the levels of 
diagnostic cardiac marker enzymes such as SGOT, LDH 
and CPK in serum of HCD induced rats is due to Peroxide 
formation induced by hypercholesterolemia in the form of 
ROS[23]. This ROS production increases cellular membrane 
permeability, intracellular fluid transfers onto intercellular 
space, resulting in muscle and cardiac damage which 
leads to the leakage or release of cardiac marker enzymes 
from cardiac tissue to serum and hence the level of marker 
enzymes are raised in HCD fed rats. There was a significant 
elevation in the levels of cardiac marker enzymes such as 
SGOT, LDH and CPK were observed in HCD induced rats 
when compared with control rats. Treatment with AEBM 
significantly reduced the activity of SGOT, LDH and CPK to 
near normal levels.
  Macroscopic observation of thoracic aorta showed that 
tenacity of vessel in control group was better than that of 
hypercholesterolemic rats.  Furthermore, surface of intima 
in rats fed with normal rat chow was smooth and glossy, and 
there is no thickening of the intima or migration of smooth 
muscle cells to the intima, whereas surface of intima of HCD 
induced rats showed a typical plaques characterized by 
thickening of the intima, migration of smooth muscle cells to 
the intima, infiltration of macrophages, appearance of foam 
and lamellar calcification under the endothelium. 
  From our result we observed that there was an increased 
foam cell formation which leads to intimal thickening in 
HCD induced group. These results were accordance with 
the reports of [51,52]. These foam cell counts were reduced 
in AEBM treated group which could be due to its inhibition 
activity on cholesteryl ester and thereby reduces the specific 
binding sites of acetyl LDL hence can reduce the foam cell 
formation and leads to less thickening of intima.
  The result obtained in this study suggests that the 
alcoholic extract of B. monniera has beneficial effects in 
preventing hypercholesterolemia by lowering lipid status, 
improving antioxidant status as well as protecting the aortic 
morphology.
  The present experimental data therefore suggest that 
alcoholic extract of B. monniera has an atheroprotective 
potential. In our laboratory we have started to work on 
major active component namely Bacoside-A from the 
plant extract for its hypocholesterolemic activity. Further 
studies are needed to check the indepth mechanism of 
hypocholesterolemic activity of AEBM at molecular level. 
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